Clinical Trials Logo

Clinical Trial Summary

This study aims to compare the Cone Beam and the multi-detector computed tomography for diagnosis and pre-operative evaluation of otosclerosis in patients addressed for conductive hearing loss with intact tympanic membrane. The study aims to show that the Cone Beam offers equivalent performances with lower radiation dosage in this indication


Clinical Trial Description

Otosclerosis is an inflammatory bone remodeling disorder of the otic capsule, characterized by spongiotic new bone formation, causing stamped ankylosis that can result in conductive hearing loss. Until now, the gold standard imaging technique for diagnosis and pre-operative evaluation of otosclerosis has been multi-detector computed tomography (MDCT). Cone Beam computed tomography is a relatively recent imaging modality. It is associated with a lower radiation dosage compared to MDCT, and a high spatial resolution that allows a more precise analysis of bone structures. During the last 15 years, its use has been increasingly common in odontology and craniofacial surgery. Several studies have already studied the utility of Cone Beam for temporal bone pathologies, including recent retrospective studies that showed satisfying diagnostic performances for otosclerosis. Up to now, very few prospective studies have compared those two imaging modalities for otosclerosis diagnosis and pre-operative evaluation. Therefore, those two exams will be performed in patients addressed to the hospital for conductive hearing loss with intact tympanic membrane. Thus, the performance of Cone Beam will be compared to MDCT, regarding the positive diagnosis of otosclerosis, the analysis of anatomical structures of the temporal bone for pre-operative evaluation, and also the benefits in terms of irradiation. The MDCTs will include fewer slices than routine MDCTs and will be centered on the area of interest, in order to keep a total radiation dosage smaller or equivalent to routine care ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05214053
Study type Interventional
Source University Hospital, Bordeaux
Contact Xavier Barreau, MD
Phone +33 5.56.79.56.04
Email [email protected]
Status Recruiting
Phase N/A
Start date January 18, 2022
Completion date December 10, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04908839 - Validation of the French Version of the Stapesplasty Outcome Test 25 (SPOT-25)
Completed NCT02901093 - Quantification of Prosthesis Penetration With Conebeam in Otosclerosis N/A
Completed NCT01855425 - Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose N/A
Completed NCT02456272 - Hearing Aid Versus Surgical Rehabilitation as Treatment of Otosclerosis: Pilot Study N/A
Completed NCT00525551 - Efficacy of Acetylcysteine in Patients Undergoing Surgery for Otosclerosis Phase 4
Active, not recruiting NCT00222417 - Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease Phase 2/Phase 3
Terminated NCT02435446 - Cone Beam and CT Scan for the Diagnosis of Otosclerosis (TACOS) N/A
Terminated NCT01617057 - Therapeutic Efficacy of Tiludronic Acid on Inner Ear Involvement in Advanced Otosclerosis Phase 3
Completed NCT03888079 - Patient Satisfaction After Surgery for Otosclerosis Under Local ou General Anesthesia
Completed NCT02019888 - Wide Frequency Band Test of Hearing in Veterans